Integrating Cancer Biomarkers into Clinical Practice This is module three of six core modules for the Biomarker Testing Navigation Certificate program. This online, interactive module discusses following standard biomarker testing protocols.
Testing protocols for common cancers
Reviewing clinical guideline recommendations
Testing in NSCLC
Testing in CRC
Target Audience
Michelle Shiller, DOMedical Director, Cancer Genetics, Baylor Sammons Cancer CenterDallas, TX
CME/CMLE Credit: 0.5Estimated Completion Time: 0.5 hourFormat: Online educational activity
Credit Designation Statement
The American Society for Clinical Pathology (ASCP) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
ASCP designates this activity for a maximum of .5 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel.
For questions regarding CMLE credit, please contact ASCP Customer Service at 1-800-267-2727, during normal business hours: Monday through Friday, 8 a.m. to 6 p.m. Eastern Time
Method of ParticipationTo complete the activity and receive credit, the participant must complete the online activity. CMLE certificates will be provided online. Commercial Support This activity is supported by a sponsorship from AstraZeneca.
Instructions
To claim CME/CMLE credit for the exercise, do the following:
Upon completion of this activity, you will be able to:
Explain the role of standardized cancer biomarker testing
Recognize clinical practice guidelines for cancer biomarker testing
Identify predictive biomarkers for advanced non-small cell lung, colorectal, and other cancers with recommended testing protocols
Apply biomarker testing to clinical cases
Analyze the current challenges and emerging trends impacting biomarker testing